These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33491667)

  • 1. Potent antitumor effects of cell-penetrating peptides targeting STAT3 axis.
    Aftabizadeh M; Li YJ; Zhao Q; Zhang C; Ambaye N; Song J; Nagao T; Lahtz C; Fakih M; Ann DK; Yu H; Herrmann A
    JCI Insight; 2021 Jan; 6(2):. PubMed ID: 33491667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting STAT3 in adoptively transferred T cells promotes their in vivo expansion and antitumor effects.
    Kujawski M; Zhang C; Herrmann A; Reckamp K; Scuto A; Jensen M; Deng J; Forman S; Figlin R; Yu H
    Cancer Res; 2010 Dec; 70(23):9599-610. PubMed ID: 21118964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cell-Derived IL35 Drives STAT3-Dependent CD8
    Mirlekar B; Michaud D; Lee SJ; Kren NP; Harris C; Greene K; Goldman EC; Gupta GP; Fields RC; Hawkins WG; DeNardo DG; Rashid NU; Yeh JJ; McRee AJ; Vincent BG; Vignali DAA; Pylayeva-Gupta Y
    Cancer Immunol Res; 2020 Mar; 8(3):292-308. PubMed ID: 32024640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR5 Blockade Suppresses Melanoma Development Through Inhibition of IL-6-Stat3 Pathway via Upregulation of SOCS3.
    Tang Q; Jiang J; Liu J
    Inflammation; 2015 Dec; 38(6):2049-56. PubMed ID: 26047948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anticancer peptide RT53 induces immunogenic cell death.
    Pasquereau-Kotula E; Habault J; Kroemer G; Poyet JL
    PLoS One; 2018; 13(8):e0201220. PubMed ID: 30080874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy.
    Wu X; Cao Y; Xiao H; Li C; Lin J
    Mol Cancer Ther; 2016 Nov; 15(11):2609-2619. PubMed ID: 27535971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of combination therapy with anti-PD-1 blockade and a STAT3 inhibitor on the tumor-infiltrating lymphocyte status.
    Ashizawa T; Iizuka A; Maeda C; Tanaka E; Kondou R; Miyata H; Sugino T; Kawata T; Deguchi S; Mitsuya K; Hayashi N; Asai A; Ito M; Yamaguchi K; Akiyama Y
    Immunol Lett; 2019 Dec; 216():43-50. PubMed ID: 31586551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells.
    Herrmann A; Priceman SJ; Swiderski P; Kujawski M; Xin H; Cherryholmes GA; Zhang W; Zhang C; Lahtz C; Kowolik C; Forman SJ; Kortylewski M; Yu H
    J Clin Invest; 2014 Jul; 124(7):2977-87. PubMed ID: 24892807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-tumor activity of the STAT3 inhibitor STX-0119 occurs via promotion of tumor-infiltrating lymphocyte accumulation in temozolomide-resistant glioblastoma cell line.
    Akiyama Y; Nonomura C; Ashizawa T; Iizuka A; Kondou R; Miyata H; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Asai A; Ito M; Kiyohara Y; Yamaguchi K
    Immunol Lett; 2017 Oct; 190():20-25. PubMed ID: 28716484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors.
    Rettman P; Blunt MD; Fulton RJ; Vallejo AF; Bastidas-Legarda LY; España-Serrano L; Polak ME; Al-Shamkhani A; Retiere C; Khakoo SI
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer Therapeutics.
    Arpin CC; Mac S; Jiang Y; Cheng H; Grimard M; Page BD; Kamocka MM; Haftchenary S; Su H; Ball DP; Rosa DA; Lai PS; Gómez-Biagi RF; Ali AM; Rana R; Hanenberg H; Kerman K; McElyea KC; Sandusky GE; Gunning PT; Fishel ML
    Mol Cancer Ther; 2016 May; 15(5):794-805. PubMed ID: 26873728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of a novel oral signal transducer and activator of transcription 3 inhibitor YHO-1701.
    Nishisaka F; Taniguchi K; Tsugane M; Hirata G; Takagi A; Asakawa N; Kurita A; Takahashi H; Ogo N; Shishido Y; Asai A
    Cancer Sci; 2020 May; 111(5):1774-1784. PubMed ID: 32112605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic antitumor effects of CpG oligodeoxynucleotide and STAT3 inhibitory agent JSI-124 in a mouse melanoma tumor model.
    Molavi O; Ma Z; Hamdy S; Lai R; Lavasanifar A; Samuel J
    Immunol Cell Biol; 2008; 86(6):506-14. PubMed ID: 18392040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model.
    Yuan L; Liu C; Chen Y; Zhang Z; Zhou L; Qu D
    Int J Nanomedicine; 2013; 8():4339-50. PubMed ID: 24235831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-2 regulates tumor-reactive CD8
    Liu Y; Zhou N; Zhou L; Wang J; Zhou Y; Zhang T; Fang Y; Deng J; Gao Y; Liang X; Lv J; Wang Z; Xie J; Xue Y; Zhang H; Ma J; Tang K; Fang Y; Cheng F; Zhang C; Dong B; Zhao Y; Yuan P; Gao Q; Zhang H; Xiao-Feng Qin F; Huang B
    Nat Immunol; 2021 Mar; 22(3):358-369. PubMed ID: 33432230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of a novel small molecule STAT3 inhibitor against a human lymphoma cell line with high STAT3 activation.
    Ashizawa T; Miyata H; Ishii H; Oshita C; Matsuno K; Masuda Y; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Akiyama Y
    Int J Oncol; 2011 May; 38(5):1245-52. PubMed ID: 21369699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Stat3 in the myeloid compartment drastically improves the in vivo antitumor functions of adoptively transferred T cells.
    Herrmann A; Kortylewski M; Kujawski M; Zhang C; Reckamp K; Armstrong B; Wang L; Kowolik C; Deng J; Figlin R; Yu H
    Cancer Res; 2010 Oct; 70(19):7455-64. PubMed ID: 20841481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A specific STAT3-binding peptide exerts antiproliferative effects and antitumor activity by inhibiting STAT3 phosphorylation and signaling.
    Kim D; Lee IH; Kim S; Choi M; Kim H; Ahn S; Saw PE; Jeon H; Lee Y; Jon S
    Cancer Res; 2014 Apr; 74(8):2144-51. PubMed ID: 24576829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of lactate-lysosome axis in dendritic cells by clotrimazole potentiates antitumor immunity.
    Wang Z; Xu F; Hu J; Zhang H; Cui L; Lu W; He W; Wang X; Li M; Zhang H; Xiong W; Xie C; Liu Y; Zhou P; Liu J; Huang P; Qin XF; Xia X
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation of the Tat cell-penetrating peptide into nanofibers improves the respective antitumor immune response.
    Mohammadi M; Dehghani P; Mohseninia A; Roozbehani M; Hemphill A; Hesamizadeh K
    J Cell Physiol; 2021 Feb; 236(2):1401-1417. PubMed ID: 32686113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.